Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The X-linked orphan receptor
GPR50
shares 45% homology with the melatonin receptors, yet its ligand and physiological function remain unknown. Here we report that mice lacking functional
GPR50
through insertion of a lacZ gene into the coding sequence of
GPR50
exhibit an altered metabolic phenotype.
GPR50
knockout mice maintained on normal chow exhibit lower body weight than age-matched wild-type littermates by 10 wk of age. Furthermore, knockout mice were partially resistant to diet-induced obesity. When placed on a high-energy diet (HED) for 5 wk, knockout mice consumed significantly more food per unit body weight yet exhibited an attenuated weight gain and reduced body fat content compared with wild-type mice. Wheel-running activity records revealed that, although
GPR50
knockout mice showed no alteration of circadian period, the overall levels of activity were significantly increased over wild types in both nocturnal and diurnal phases. In line with this, basal metabolic rate (O2 consumption, CO2 production, and respiratory quotient) was found to be elevated in knockout mice. Using in situ hybridization (wild-type mice) and
beta-galactosidase
activity (from LacZ insertion element in knockout mice), brain expression of
GPR50
was found to be restricted to the ependymal layer of the third ventricle and dorsomedial nucleus of the hypothalamus.
GPR50
expression was highly responsive to energy status, showing a significantly reduced expression following both fasting and 5 wk of HED. These data implicate
GPR50
as an important regulator of energy metabolism.
...
PMID:Altered metabolism in the melatonin-related receptor (GPR50) knockout mouse. 1795 37